OPEN Health and fusion announce partnership to deliver AI-powered healthcare communications
June 24, 2024
London, June 24, 2024 (GLOBE NEWSWIRE) — June 24, 2024,
June 24, 2024
OPEN Health and fusion announce partnership to deliver AI-powered healthcare communications
June 24, 2024
London, June 24, 2024 (GLOBE NEWSWIRE) — June 24, 2024,
Allecra Therapeutics and Acino Sign Exclusive Licensing and Supply Agreement for Allecra’s Novel Antibiotic EXBLIFEP® in Gulf Cooperation Council countries and South Africa
June 24, 2024
Acino gains commercial rights for EXBLIFEP® (cefepime/enmetazobactam) within the member
Allecra Therapeutics and Acino Sign Exclusive Licensing and Supply Agreement for Allecra’s Novel Antibiotic EXBLIFEP® in Gulf Cooperation Council countries and South Africa
June 24, 2024
Acino gains commercial rights for EXBLIFEP® (cefepime/enmetazobactam) within the member